| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-10-13 | NCT07872423 Phase III Trial of VDJ001 In Patients With Idiopathic Multicentric Castleman Disease | Phase 3 | Recruiting |
| Phase 2 | 1 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07872423 | Phase III Trial of VDJ001 In Patients With Idiopathic Multicentric Castleman Disease | Anti IL-6R | Recruiting | 2026-10-13 |
| NCT06726096 | Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis | Rheumatoid Arthritis (RA) | Enrolling by Invitation | 2025-08-11 |
| Phase 2 | ||||
| NCT05345522 | A Study of Anti-IL-6R mAb Injection in Patients With iMCD | Idiopathic Multicentric Castleman's Disease | Active, Not Recruiting | 2025-08-08 |